Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers:A EUROmediCAT Study
Research on associations between medication use during pregnancy and congenital anomalies is significative for assessing the safe use of a medicine in pregnancy. Congenital anomaly (CA) registries do not have optimal information on medicine exposure, in contrast to prescription databases. Linkage of prescription databases to the CA registries is a potentially effective method of obtaining accurate information on medicine use in pregnancies and the risk of congenital anomalies. We linked data from primary care and prescription databases to five European Surveillance of Congenital Anomalies (EUR... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2015 |
Reihe/Periodikum: | de Jonge , L , Garne , E , Gini , R , Jordan , S E , Klungsoyr , K , Loane , M , Neville , A J , Pierini , A , Puccini , A , Thayer , D S , Tucker , D , Hansen , A V & Bakker , M K 2015 , ' Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers : A EUROmediCAT Study ' , Drug Safety , vol. 38 , no. 11 , pp. 1083-1093 . https://doi.org/10.1007/s40264-015-0321-9 |
Schlagwörter: | PREGNANCY / HEALTH / ARCHITECTURE / NETHERLANDS |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26825128 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/456a4ab9-f281-4f1f-af3c-6712b86bb731 |